TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts December 19, 1980
TCL Archive In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors February 27, 1998